About CAR T-Cell Therapy
This information is developed to help patients and their caregivers prepare for CAR T-cell therapy.
Chimeric antigen receptor (CAR) T-cell therapy is a type of cellular therapy that changes some of your body’s T-cells (which are part of your immune system) to improve your immune system’s ability to fight your cancer.
You will be carefully evaluated by your care team to determine if CAR T-cell therapy is right for treating your cancer. CAR T-cell therapy may be part of your treatment plan as standard of care, or as part of a clinical trial. You may receive your treatment while staying in the hospital or as an outpatient. Your physician will decide which approach is best for you. We encourage you to ask your care team questions to ensure you understand the process, risks, and resources available to you.
CAR T-cell therapy is a complex process and it is important that you and your caregivers are aware of these significant side effects. Your care team can answer any questions throughout the process.
Chimeric antigen receptor (CAR) T-cell therapy is a type of cellular therapy that changes some of your body’s T-cells (which are part of your immune system) to improve your immune system’s ability to fight your cancer.
You will be carefully evaluated by your care team to determine if CAR T-cell therapy is right for treating your cancer. CAR T-cell therapy may be part of your treatment plan as standard of care, or as part of a clinical trial. You may receive your treatment while staying in the hospital or as an outpatient. Your physician will decide which approach is best for you. We encourage you to ask your care team questions to ensure you understand the process, risks, and resources available to you.
CAR T-cell therapy is a complex process and it is important that you and your caregivers are aware of these significant side effects. Your care team can answer any questions throughout the process.
Clinical care provided by:
|
|